Polen Capital, an investment management company, released its Q3 2026 investor letter for its "5Perspectives Growth Opportunities Strategy". The letter can be downloaded here. The Portfolio fell 6.2% in Q3 2026, underperforming the Russell 3000 Growth Index's 0.5% gain. Twist Bioscience, CrowdStrike, and an underweight in Micron helped relative performance, while Argan, an underweight in Microsoft, and Bloom Energy detracted. Despite market volatility, the team sees AI fundamentals as intact and is gradually shifting focus from AI infrastructure suppliers toward businesses applying AI to boost productivity and develop new offerings. Also, check the Fund's top five holdings to see its best picks for 2026.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。